SKYVIEW INVESTMENT ADVISORS, LLC Eucrates Biomedical Acquisition Corp. Transaction History

SKYVIEW INVESTMENT ADVISORS, LLC portfolio value:

$719,000
portfolio value

SKYVIEW INVESTMENT ADVISORS, LLC quarter portfolio value change:

+1.21%
quarter

Eucrates Biomedical Acquisition Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 9K $10.02 71.77K
Q2 2022 share 0.00% 0 shares 4K $9.9 71.77K
Q1 2022 share 0.00% 0 shares 5K $9.84 71.77K
Q4 2021 share Increase +7.99% 5.31K shares 51K $9.82 71.77K
Q3 2021 share Increase 0.00% 66.46K shares 650K $9.78 66.46K